- Home
- KALA vs SWVL Comparison
KALA vs SWVL Comparison
Compare KALA & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- SWVL
- Stock Information
- Founded
- KALA 2009
- SWVL 2017
- Country
- KALA United States
- SWVL United Arab Emirates
- Employees
- KALA N/A
- SWVL N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- KALA Health Care
- SWVL Consumer Discretionary
- Exchange
- KALA Nasdaq
- SWVL Nasdaq
- Market Cap
- KALA 26.2M
- SWVL 30.3M
- IPO Year
- KALA 2017
- SWVL N/A
- Fundamental
- Price
- KALA $0.81
- SWVL $3.30
- Analyst Decision
- KALA Buy
- SWVL
- Analyst Count
- KALA 3
- SWVL 0
- Target Price
- KALA $31.50
- SWVL N/A
- AVG Volume (30 Days)
- KALA 1.3M
- SWVL 9.3K
- Earning Date
- KALA 11-07-2025
- SWVL 09-08-2025
- Dividend Yield
- KALA N/A
- SWVL N/A
- EPS Growth
- KALA N/A
- SWVL N/A
- EPS
- KALA N/A
- SWVL N/A
- Revenue
- KALA N/A
- SWVL $19,329,423.00
- Revenue This Year
- KALA N/A
- SWVL N/A
- Revenue Next Year
- KALA N/A
- SWVL N/A
- P/E Ratio
- KALA N/A
- SWVL N/A
- Revenue Growth
- KALA N/A
- SWVL N/A
- 52 Week Low
- KALA $0.77
- SWVL $2.40
- 52 Week High
- KALA $20.60
- SWVL $7.50
- Technical
- Relative Strength Index (RSI)
- KALA 26.24
- SWVL 52.67
- Support Level
- KALA $0.77
- SWVL $3.04
- Resistance Level
- KALA $1.52
- SWVL $3.18
- Average True Range (ATR)
- KALA 0.10
- SWVL 0.19
- MACD
- KALA 0.31
- SWVL 0.03
- Stochastic Oscillator
- KALA 4.56
- SWVL 62.51
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.